FAN
IBRX icon

Financial Advisors Network’s ImmunityBio IBRX Stock Holding History

Financial Advisors Network’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.7K Sell
10,000
-44,050
-81% -$302K 0.01% 202
2025
Q4 		$107K Buy
54,050
+4,050
+8% +$9.18K 0.01% 194
2025
Q3 		$123K Buy
50,000
+20,000
+67% +$51.5K 0.02% 194
2025
Q2 		$79.2K Buy
+30,000
New +$80.7K 0.01% 187
2025
Q1 		– Sell
-20,000
Closed -$51.2K – 196
2024
Q4 		$51.2K Buy
+20,000
New +$83.3K 0.01% 186

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Financial Advisors Network's IBRX Position: Q1 2026 in Review

Financial Advisors Network reduced its ImmunityBio (IBRX) stake by 81% in Q1 2026, selling an estimated $302K and leaving 10,000 shares worth $76.7K. The position accounts for 0.01% of the portfolio, ranked #202.

Financial Advisors Network first reported a position in IBRX in Q4 2024 and has held it in 5 quarters since. The position peaked at $123K in Q3 2025. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Financial Advisors Network held 10,000 shares of ImmunityBio worth $76.7K as of Q1 2026.
  • Financial Advisors Network sold 44,050 ImmunityBio shares in Q1 2026, an estimated $302K.
  • ImmunityBio made up 0.01% of Financial Advisors Network's portfolio in Q1 2026, its #202 holding.
  • Financial Advisors Network first reported a position in ImmunityBio in Q4 2024 and has held it in 5 quarters since.
  • Financial Advisors Network's ImmunityBio position peaked at $123K in Q3 2025.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Financial Advisors Network's 13F filing for Q1 2026, filed 15 May 2026.